advancing innovation to save lives

The Hill features op-ed from GHTC director

The Hill featured an op-ed from GHTC Director Jamie Bay Nishi which highlights the historic decline in US government investment in neglected disease R&D and calls for the US to increase funding and reassert American leadership in global health innovation.
View

Pipeline of Promise

Learn about the global health R&D process through our interactive Pipeline of Promise infographic.
Learn More

International Partnership For Microbicides

The International Partnerships for Microbicides (IPM) is a nonprofit organization that developed the monthly dapivirine ring, and is dedicated to accelerating the development and availability of other new HIV prevention tools for women in developing countries.
Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We are a coalition of more than 25 nonprofit organizations advancing policies to accelerate the creation of new drugs, vaccines, diagnostics, and other health tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity in reach for all people.

Learn more
GHTC, PATH, GHC
GHTC delivers statement on WHO R&D observatory, pooled fund at WHA

GHTC delivered a statement at the 70th World Health Assembly (WHA) calling for the rapid operationalization and full funding for the World Health Organization Global Observatory on Health Research and Development and supporting efforts to establish a health R&D pooled fund. The statement, which was issued in partnership with the Global Health Council and PATH, also encourages exploration of innovative funding sources to attract new funding for the observatory and pooled fund and calls for continued transparency to ensure these operations are grounded in sound science and public health.

PDF
PATH/Gabe Bienczycki
IP Watch covers GHTC co-hosted event

IP Watch covered the May 22 WHA side-event entitled "Investing in Innovative Health R&D Tools to Address Antimicrobial Resistance and Achieve the SDGs" hosted by GHTC, COHRED, PATH, TB Alliance, MMV, and GHC.

PDF
View All News & Events

Community Event

McGill University
McGill Summer Institute in Infectious Diseases and Global Health
McGill University
Learn More
View All Events
PATH/Evelyn Hockstein
CDC in Kibera: Closely monitoring diseases, outbreaks in a slum

Inside a large room at the US Embassy in Nairobi, Robert F. Breiman, MD, the country director for the Centers for Disease Control and Prevention (CDC) in Kenya, explained a portion of the US-funded research in Nairobi’s largest slum, Kibera.

Read More
alex-dehgan
Global Health R&D with USAID's Alex Dehgan

During USAID’s 50th year, there’s a lot of talk about helping women in the developing world.

GHTC
Read More
View Breakthroughs Blog

Our members work to improve health worldwide